Vycor Medical (VYCO) Cash from Investing Activities (2010 - 2026)
Vycor Medical's (VYCO) quarterly Cash from Investing Activities came in at $342.0 in Q2 2026, down 84.02% quarter-over-quarter from $2140.0 in Q1 2026.
Powered by 
Analysis
Vycor Medical (VYCO) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Cash from Investing Activities for 17 consecutive years, with $342.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to $342.0 in Q2 2026; TTM through Jun 2026 was $876.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$4383.0, down 4.38% from the prior year.
- Cash from Investing Activities was $342.0 for Q2 2026 at Vycor Medical, down from $2140.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $2140.0 in Q1 2026 and troughed at -$5904.0 in Q4 2023.
- A 5-year average of -$1024.2 and a median of $212.0 in 2023 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities tumbled 4291.67% in 2023 and soared 129.86% in 2024, its largest moves.
- Over 5 years, Cash from Investing Activities stood at $322.0 in 2022, then tumbled by 1933.54% to -$5904.0 in 2023, then soared by 102.88% to $170.0 in 2024, then slumped by 1044.71% to -$1606.0 in 2025, then surged by 121.3% to $342.0 in 2026.
- The last three Cash from Investing Activities figures came in at $342.0 (Q2 2026), $2140.0 (Q1 2026), and -$1606.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | 342.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 342.00 |
| Mar 31, 2026 | 2,140.00 |
| Dec 31, 2025 | -1,606.00 |
| Dec 31, 2024 | 170.00 |
| Sep 30, 2024 | -5,031.00 |
| Mar 31, 2024 | 662.00 |
| Dec 31, 2023 | -5,904.00 |
| Sep 30, 2023 | -4,024.00 |
| Jun 30, 2023 | 254.00 |
| Mar 31, 2023 | 288.00 |
| Dec 31, 2022 | 322.00 |
| Sep 30, 2022 | 96.00 |
| Dec 31, 2021 | 315.00 |
| Sep 30, 2021 | -6,448.00 |
| Jun 30, 2021 | -8,307.00 |
| Mar 31, 2021 | -23,935.00 |
| Dec 31, 2020 | -1,920.00 |
| Sep 30, 2020 | -191.00 |
| Jun 30, 2020 | -4,596.00 |
| Mar 31, 2020 | -45,771.00 |